Concepedia

Neil Parkin

NP

Statistics

Publications

99

Citations

7.7K

H-Index

47

Active since

1988

Affiliations

First Consulting Group (United States)(Current)

VIR Biotechnology (United States)

Johns Hopkins University

Johns Hopkins Medicine

University of North Carolina at Chapel Hill

Neil Parkin is an author at First Consulting Group (United States) specializing in life sciences, molecular virology, and virology.

ORCID

Publications per year

1988–2022

99

Publications

99

A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Christos J. Petropoulos, Neil Parkin, Kay Limoli et al. · Antimicrobial Agents and Chemotherapy · 2000 · 653 citations

, , +17

Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness

David R. Bangsberg, Edward P. Acosta, Reena Gupta et al. · AIDS · 2006 · 316 citations

, , +16

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

Mina C. Hosseinipour, Joep JG van Oosterhout, Ralf Weigel et al. · AIDS · 2009 · 285 citations · Full text

, , +17

Evidence for Positive Epistasis in HIV-1

Sebastian Bonhoeffer, Colombe Chappey, Neil Parkin et al. · Science · 2004 · 283 citations

, , +17

Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

Susan J. Little, Simon D. W. Frost, Joseph K. Wong et al. · Journal of Virology · 2008 · 252 citations

, , +17

1–5 of 99